Harish Vashisth, associate professor of chemical engineering and integrated applied mathematics at the University of New Hampshire, is leading a research team whose work can help lead to the development of new targeted drugs to treat metabolic, growth, neurological and visual disorders, including diabetes and cancer.

UNH received $1.8 million from the National Institutes of Health to further the research.

Vashisth and his team will use computational techniques combined with experimental data to explore new and more suitable stages in the signaling cycle of a cell protein to target drug interventions.